Prognostic Role of 68Ga-PSMA11 PET–Based Response in Patients with Prostate Cancer Undergoing Taxane-Based Chemotherapy

Lukas Lunger; Maythinee Chantadisai; Amir Karimzadeh; Isabel Rauscher; Calogero D’Alessandria; Benedikt Feuerecker; Thomas Langbein; Robert Tauber; Stefan Schiele; Wolfgang Weber; Matthias Eiber

doi:10.2967/jnumed.122.264962

Research ArticleClinical Investigations

Prognostic Role of ⁶⁸Ga-PSMA11 PET–Based Response in Patients with Prostate Cancer Undergoing Taxane-Based Chemotherapy

Lukas Lunger, Maythinee Chantadisai, Amir Karimzadeh, Isabel Rauscher, Calogero D’Alessandria, Benedikt Feuerecker, Thomas Langbein, Robert Tauber, Stefan Schiele, Wolfgang Weber and Matthias Eiber

Journal of Nuclear Medicine June 2023, 64 (6) 896-901; DOI: https://doi.org/10.2967/jnumed.122.264962

Lukas Lunger

1Department of Urology, Rechts der Isar Medical Center, Technical University of Munich, Munich, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Maythinee Chantadisai

2Department of Nuclear Medicine, Rechts der Isar Medical Center, Technical University of Munich, Munich, Germany; and

3Division of Nuclear Medicine, Department of Radiology, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, The Thai Red Cross Society, Bangkok, Thailand

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Amir Karimzadeh

2Department of Nuclear Medicine, Rechts der Isar Medical Center, Technical University of Munich, Munich, Germany; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Isabel Rauscher

2Department of Nuclear Medicine, Rechts der Isar Medical Center, Technical University of Munich, Munich, Germany; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Calogero D’Alessandria

2Department of Nuclear Medicine, Rechts der Isar Medical Center, Technical University of Munich, Munich, Germany; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Benedikt Feuerecker

2Department of Nuclear Medicine, Rechts der Isar Medical Center, Technical University of Munich, Munich, Germany; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Thomas Langbein

2Department of Nuclear Medicine, Rechts der Isar Medical Center, Technical University of Munich, Munich, Germany; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Robert Tauber

1Department of Urology, Rechts der Isar Medical Center, Technical University of Munich, Munich, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Stefan Schiele

1Department of Urology, Rechts der Isar Medical Center, Technical University of Munich, Munich, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Wolfgang Weber

2Department of Nuclear Medicine, Rechts der Isar Medical Center, Technical University of Munich, Munich, Germany; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Matthias Eiber

2Department of Nuclear Medicine, Rechts der Isar Medical Center, Technical University of Munich, Munich, Germany; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Data supplements

Supplemental Data

Files in this Data Supplement:

Supplemental Data

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 64, Issue 6

June 1, 2023

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Complete Issue (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Prognostic Role of 68Ga-PSMA11 PET–Based Response in Patients with Prostate Cancer Undergoing Taxane-Based Chemotherapy

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Prognostic Role of ⁶⁸Ga-PSMA11 PET–Based Response in Patients with Prostate Cancer Undergoing Taxane-Based Chemotherapy

Lukas Lunger, Maythinee Chantadisai, Amir Karimzadeh, Isabel Rauscher, Calogero D’Alessandria, Benedikt Feuerecker, Thomas Langbein, Robert Tauber, Stefan Schiele, Wolfgang Weber, Matthias Eiber

Journal of Nuclear Medicine Jun 2023, 64 (6) 896-901; DOI: 10.2967/jnumed.122.264962

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Prognostic Role of ⁶⁸Ga-PSMA11 PET–Based Response in Patients with Prostate Cancer Undergoing Taxane-Based Chemotherapy

Lukas Lunger, Maythinee Chantadisai, Amir Karimzadeh, Isabel Rauscher, Calogero D’Alessandria, Benedikt Feuerecker, Thomas Langbein, Robert Tauber, Stefan Schiele, Wolfgang Weber, Matthias Eiber

Journal of Nuclear Medicine Jun 2023, 64 (6) 896-901; DOI: 10.2967/jnumed.122.264962

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

PubMed
Google Scholar

Cited By...

No citing articles found.

Google Scholar

Keywords

metastatic prostate cancer
taxane-based chemotherapy
68Ga-PSMA11 PET/CT
treatment monitoring
survival

Main menu

User menu

Search

Prognostic Role of ⁶⁸Ga-PSMA11 PET–Based Response in Patients with Prostate Cancer Undergoing Taxane-Based Chemotherapy

Data supplements

Supplemental Data

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords